The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Thrombolytic Therapy vs Primary Percutaneous Coronary Intervention for Myocardial Infarction in Patients Presenting to Hospitals Without On-site Cardiac Surgery<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
Abstract
CONTEXT: Trials comparing primary percutaneous coronary intervention (PCI) and thrombolytic therapy for treatment of acute myocardial infarction (MI) suggest primary PCI is the superior therapy, although they differ with respect to the durability of benefit. Because PCI is often limited to hospitals that have on-site cardiac surgery programs, most acute MI patients do not have access to this therapy. OBJECTIVE: To determine whether treatment of acute MI with primary PCI is superior to thrombolytic therapy at hospitals without on-site cardiac surgery and, if so, whether superiority is durable. DESIGN: The Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT) trial, a prospective, randomized trial conducted from July 1996 through December 1999. SETTING: Eleven community hospitals in Massachusetts and Maryland without on-site cardiac surgery or extant PCI programs. PATIENTS: Four hundred fifty-one thrombolytic-eligible patients with acute MI of less than 12 hours' duration associated with ST-segment elevation on electrocardiogram. INTERVENTIONS: After a formal primary PCI development program was completed at all sites, patients were randomly assigned to receive primary PCI (n = 225) or accelerated tissue plasminogen activator (bolus dose of 15 mg and an infusion of 0.75 mg/kg for 30 minutes followed by 0.5 mg/kg for 60 minutes; n = 226). After initiation of assigned treatment, all care was determined by treating physicians. MAIN OUTCOME MEASURES: Six-month composite incidence of death, recurrent MI, and stroke; median hospital length of stay. RESULTS: The incidence of the composite end point was reduced in the primary PCI group at 6 weeks (10.7% vs 17.7%; P =.03) and 6 months (12.4% vs 19.9%; P =.03) after index MI. Six-month rates for individual outcomes were 6.2% vs 7.1% for death (P =.72), 5.3% vs 10.6% for recurrent MI (P =.04), and 2.2% vs 4.0% for stroke (P =.28) for primary PCI vs thrombolytic therapy, respectively. Median length of stay was also reduced in the primary PCI group (4.5 vs 6.0 days; P =.02). CONCLUSIONS: Compared with thrombolytic therapy, treatment of patients with primary PCI at hospitals without on-site cardiac surgery is associated with better clinical outcomes for 6 months after index MI and a shorter hospital stay.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ryan, T. J., Faxon, D. P., Gunnar, R. M., Kennedy, J. W., King, S. B., Loop, F. D., Peterson, K. L., Reeves, T. J., Williams, D. O., & Winters, W. L. (1988) · Circulation · doi:10.1161/01.cir.78.2.486 · Cited by 2,123
A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction
Grines, C. L., Browne, K. F., Marco, J., Rothbaum, D., Stone, G. W., O'Keefe, J., Overlie, P., Donohue, B., Chelliah, N., Timmis, G. C., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303113281001 · Cited by 1,995
ACC/AHA guidelines for the management of patients with acute myocardial infarction
Committee Members, Ryan, T. J., Anderson, J. L., Antman, E. M., Braniff, B. A., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00392-0 · Cited by 1,850
Zijlstra, F., de Boer, M. J., Hoorntje, J., Reiffers, S., Reiber, J., & Suryapranata, H. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303113281002 · Cited by 1,290
Cannon, C. P. (2000) · JAMA · doi:10.1001/jama.283.22.2941 · Cited by 1,222
Guidelines for percutaneous transluminal coronary angioplasty
Ryan, T. J. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90431-7 · Cited by 1,029
Weaver, W. D. (1997) · JAMA · doi:10.1001/jama.1997.03550230069040 · Cited by 1,005
Tube Feeding in Patients With Advanced Dementia: A Review of the Evidence
Finucane, T. E., Christmas, C., & Travis, K. (1999) · JAMA · doi:10.1001/jama.282.14.1365 · Cited by 1,004
(1997) · New England Journal of Medicine · doi:10.1056/nejm199706053362301 · Cited by 948
Van de Werf, F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)07403-6 · Cited by 885
Cited by
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Keeley, E. C., Boura, J. A., & Grines, C. L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12113-7 · Cited by 4,361
Writing Committee Members, Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823ba622 · Cited by 3,289
WRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,218
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.007 · Cited by 2,164
Metadata
- Authors
- Aversano, T.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2002-04-17
- Volume
- 287
- Issue
- 15
- Pages
- 1943
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2032578967
- Cited by
- 346
- References
- 22
- FWCI
- 24.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thrombolytic Therapy vs Primary Percutaneous Coronary Intervention for Myocardial Infarction in Patients Presenting to Hospitals Without On-site Cardiac Surgery<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>. https://app.cochat.ai/papers/10.1001/jama.287.15.1943
- The paper
- Aversano, T. (2002). Thrombolytic Therapy vs Primary Percutaneous Coronary Intervention for Myocardial Infarction in Patients Presenting to Hospitals Without On-site Cardiac Surgery<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>. JAMA. https://doi.org/10.1001/jama.287.15.1943
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.